Can the new adipokine asprosin be a metabolic troublemaker for cardiovascular diseases? A state-of-the-art review
出版年份 2023 全文链接
标题
Can the new adipokine asprosin be a metabolic troublemaker for cardiovascular diseases? A state-of-the-art review
作者
关键词
-
出版物
PROGRESS IN LIPID RESEARCH
Volume 91, Issue -, Pages 101240
出版商
Elsevier BV
发表日期
2023-07-19
DOI
10.1016/j.plipres.2023.101240
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Asprosin aggravates vascular endothelial dysfunction via disturbing mitochondrial dynamics in obesity models
- (2023) Yanli Lu et al. Obesity
- The role of irisin and asprosin level in the pathophysiology of prediabetes
- (2023) Gokcen Nailer Ertuna et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Asprosin Enhances Cytokine Production by a Co-Culture of Fully Differentiated Mature Adipocytes and Macrophages Leading to the Exacerbation of the Condition Typical of Obesity-Related Inflammation
- (2023) Agnieszka I. Mazur-Bialy INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular cloning, characterization and 3D modelling of spotted snakehead fbn1 C-terminal region encoding asprosin and expression analysis of fbn1
- (2023) Priyanka Sathoria et al. Scientific Reports
- Acute effect of moderate and high-intensity interval exercises on asprosin and BDNF levels in inactive normal weight and obese individuals
- (2023) Halil İbrahim Ceylan et al. Scientific Reports
- Asprosin promotes feeding through SK channel–dependent activation of AgRP neurons
- (2023) Bing Feng et al. Science Advances
- Sensitive asprosin detection in clinical samples reveals serum/saliva correlation and indicates cartilage as source for serum asprosin
- (2022) Yousef A. T. Morcos et al. Scientific Reports
- Correlation of metabolic characteristics with maternal, fetal and placental asprosin in human pregnancy
- (2022) Thorben Hoffmann et al. Endocrine Connections
- Association of maternal and umbilical cord blood asprosin with excessive gestational weight gain
- (2022) Fatemeh Behrasi et al. NUTRITION BULLETIN
- Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease
- (2022) Mei You et al. Cardiovascular Diabetology
- Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor
- (2022) Ila Mishra et al. Cell Metabolism
- A cross-sectional comparative study on the effects of body mass index and exercise/sedentary on serum asprosin in male college students
- (2022) Ruiqi Huang et al. PLoS One
- Designing antibodies as therapeutics
- (2022) Paul J. Carter et al. CELL
- Association between circulating Asprosin levels and carotid atherosclerotic plaque in patients with type 2 diabetes
- (2022) Xia Deng et al. CLINICAL BIOCHEMISTRY
- Asprosin modulates testicular functions during ageing in mice
- (2022) Sangeeta Maurya et al. GENERAL AND COMPARATIVE ENDOCRINOLOGY
- Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38/Elk-1 pathway
- (2022) Jin Zou et al. Journal of Translational Medicine
- Investigation of serum and adipose tissue levels of asprosin in patients with severe obesity undergoing sleeve gastrectomy
- (2022) Hasan Cantay et al. Obesity
- Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer
- (2022) Andre Lima Queiroz et al. Nature Communications
- Association Between Serum Asprosin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in the Community: A Cross-Sectional Study
- (2022) Linxin Xu et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Asprosin promotes steroidogenesis and spermatogenesis with improved glucose metabolism in adult mice testis
- (2022) Sangeeta Maurya et al. ANDROLOGIA
- Asprosin in the Paraventricular Nucleus Induces Sympathetic Activation and Pressor Responses via cAMP-Dependent ROS Production
- (2022) Xiao-Li Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of GLP-1 receptor agonists on asprosin levels in normal weight or overweight/obesity patients with type 2 diabetes mellitus
- (2022) Chenggang Dai et al. MEDICINE
- Apelin-13 and Asprosin in Adolescents with Anorexia Nervosa and Their Association with Psychometric and Metabolic Variables
- (2022) Katarzyna Jowik et al. Nutrients
- Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men
- (2022) Tingting Yao et al. Frontiers in Physiology
- Asprosin Exacerbates Endothelium Inflammation Induced by Hyperlipidemia Through Activating IKKβ-NF-κBp65 Pathway
- (2022) Qianqian Huang et al. INFLAMMATION
- Angiogenesis–Browning Interplay Mediated by Asprosin-Knockout Contributes to Weight Loss in Mice with Obesity
- (2022) Tingting Yin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Asprosin Exerts Pro-Inflammatory Effects in THP-1 Macrophages Mediated via the Toll-like Receptor 4 (TLR4) Pathway
- (2022) Kiran Shabir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adiponectin, Leptin and Cardiovascular Disorders
- (2021) Shangang Zhao et al. CIRCULATION RESEARCH
- Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue
- (2021) Yanli Miao et al. JOURNAL OF ENDOCRINOLOGY
- Association of serum asprosin concentrations with obstructive sleep apnea syndrome
- (2021) Jurong Ding et al. Sleep and Breathing
- High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome
- (2021) Tao Hong et al. International Journal of Endocrinology
- Neuroscientific Therapies for Atrial Fibrillation
- (2021) Peter Hanna et al. CARDIOVASCULAR RESEARCH
- The sympathetic nervous system and ventricular arrhythmias: an inseparable union
- (2021) Filippo Maria Cauti et al. EUROPEAN HEART JOURNAL
- Plasma asprosin, CCDC80 and ANGPTL4 levels are associated with metabolic and cardiovascular risk in patients with inflammatory bowel disease
- (2021) Hao-Hua Wang et al. PHYSIOLOGICAL RESEARCH
- Effect of sodium–glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus
- (2021) Aijun Jiang et al. Diabetology & Metabolic Syndrome
- Increased serum asprosin is correlated with diabetic nephropathy
- (2021) Rui Wang et al. Diabetology & Metabolic Syndrome
- CENTRAL AND PERIPHERAL SYMPATHETIC ACTIVATION IN HEART FAILURE
- (2021) Guido Grassi et al. CARDIOVASCULAR RESEARCH
- Asprosin serum levels and glucose homeostasis in children with obesity
- (2021) Domenico Corica et al. CYTOKINE
- Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence
- (2021) Kiran Shabir et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases
- (2021) Monika Barteková et al. FREE RADICAL BIOLOGY AND MEDICINE
- Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study
- (2021) Nariman Moradi et al. Lipids in Health and Disease
- Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy
- (2021) Golnoosh Goodarzi et al. MOLECULAR BIOLOGY REPORTS
- Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
- (2021) Suowen Xu et al. PHARMACOLOGICAL REVIEWS
- Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity
- (2021) Lu-Jie Liu et al. World Journal of Pediatrics
- Nordic Walking at Maximal Fat Oxidation Intensity Decreases Circulating Asprosin and Visceral Obesity in Women With Metabolic Disorders
- (2021) Malgorzata Kantorowicz et al. Frontiers in Physiology
- Marfan syndrome
- (2021) Dianna M. Milewicz et al. Nature Reviews Disease Primers
- A Serum Marker for Early Pancreatic Cancer With a Possible Link to Diabetes
- (2021) Hoonsik Nam et al. JNCI-Journal of the National Cancer Institute
- Intracerebroventricular asprosin administration strongly stimulates hypothalamic-pituitary-testicular axis in rats
- (2021) Tuba Keskin et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- A potential role of fibrillin-1 (FBN1) mRNA and asprosin in follicular development in water buffalo
- (2021) Excel Rio S. Maylem et al. THERIOGENOLOGY
- Caudamins, a new subclass of protein hormones
- (2021) Bijoya Basu et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Are adropin, apelin, elabela, asprosin and betatrophin biomarkers for chronic hepatitis and staging of fibrosis?
- (2020) G. Eser Karlidag et al. BIOTECHNIC & HISTOCHEMISTRY
- Increased Serum Circulating Asprosin Levels in Children with Obesity
- (2020) Eda Sünnetçi Silistre et al. PEDIATRICS INTERNATIONAL
- ALTERED BLOOD AND AQUEOUS HUMOR LEVELS OF ASPROSIN, 4-HYDROXYNONENAL, AND 8-HYDROXY-DEOXYGUANOSINE IN PATIENTS WITH DIABETES MELLITUS AND CATARACT WITH AND WITHOUT DIABETIC RETINOPATHY
- (2020) Yavuz Oruc et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- The modulatory effects of irisin on asprosin, leptin, glucose levels and lipid profile in healthy and obese male and female rats
- (2020) Sibel Ozcan et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Placensin is a glucogenic hormone secreted by human placenta
- (2020) Yiping Yu et al. EMBO REPORTS
- Targeting cardiovascular inflammation: next steps in clinical translation
- (2020) Patrick R Lawler et al. EUROPEAN HEART JOURNAL
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease
- (2020) Hongyu Zhang et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Continuous elevation of plasma asprosin in pregnant women complicated with gestational diabetes mellitus: A nested case-control study
- (2020) Lieqiang Zhong et al. PLACENTA
- Asprosin promotes β‐cell apoptosis by inhibiting the autophagy of β‐cell via AMPK‐mTOR pathway
- (2020) Rui Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Asprosin is associated with anorexia and body fat mass in cancer patients
- (2020) Cheng Du et al. SUPPORTIVE CARE IN CANCER
- Serum concentration of asprosin in new-onset type 2 diabetes
- (2020) Shakiba Naiemian et al. Diabetology & Metabolic Syndrome
- The role of Asprosin in patients with dilated cardiomyopathy
- (2020) Ming-Shien Wen et al. BMC Cardiovascular Disorders
- Assessment of acute aerobic exercise in the morning versus evening on asprosin, spexin, lipocalin-2, and insulin level in overweight/obese versus normal weight adult men
- (2020) Halil İbrahim Ceylan et al. CHRONOBIOLOGY INTERNATIONAL
- Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease
- (2020) Fan Ke et al. CYTOKINE
- Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin
- (2020) Nevzat Gozel et al. Endokrynologia Polska
- Discovery of a possible role of asprosin in ovarian follicular function
- (2020) Excel Rio S Maylem et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Expression of asprosin in rat hepatic, renal, heart, gastric, testicular and brain tissues and its changes in a streptozotocin-induced diabetes mellitus model
- (2020) Nevin Kocaman et al. TISSUE & CELL
- Fasted plasma asprosin concentrations are associated with menstrual cycle phase, oral contraceptive use and training status in healthy women
- (2020) A. N. Leonard et al. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- (2020) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.
- (2020) Hidetaka Wakabayashi et al. Journal of Cachexia Sarcopenia and Muscle
- Expression and purification of asprosin in Pichia pastoris and investigation of its increase glucose uptake activity in skeletal muscle through activation of AMPK
- (2020) Yunhua Zhang et al. ENZYME AND MICROBIAL TECHNOLOGY
- Maternal exposure to air pollution and umbilical asprosin concentration, a novel insulin-resistant marker
- (2020) Zeynab Sadat Hosseini et al. CHEMOSPHERE
- PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes
- (2019) George R. Uhl et al. Annals of the New York Academy of Sciences
- Saliva and Blood Asprosin Hormone Concentration Associated with Obesity
- (2019) Kader Ugur et al. International Journal of Endocrinology
- Sedentary Behavior, Exercise, and Cardiovascular Health
- (2019) Carl J. Lavie et al. CIRCULATION RESEARCH
- Case Reports of Pre-clinical Replication Studies in Metabolism and Diabetes
- (2019) Matthias von Herrath et al. Cell Metabolism
- Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscle
- (2019) Tae Woo Jung et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation
- (2019) Taeseung Lee et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Adverse organogenesis and predisposed long-term metabolic syndrome from prenatal exposure to fine particulate matter
- (2019) Guoyao Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
- (2019) Chia Lin Chang et al. Scientific Reports
- Aerobic Exercise Training Decreases Hepatic Asprosin in Diabetic Rats
- (2019) Jeong Rim Ko et al. Journal of Clinical Medicine
- OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin
- (2019) Erwei Li et al. Cell Metabolism
- Decreased Circulating Levels of Asprosin in Obese Children
- (2019) Wenjun Long et al. Hormone Research in Paediatrics
- Renal Denervation Update From the International Sympathetic Nervous System Summit
- (2019) Márcio G. Kiuchi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The endocrine function of adipose tissues in health and cardiometabolic disease
- (2019) Ludger Scheja et al. Nature Reviews Endocrinology
- Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway
- (2019) Zhengbin Zhang et al. LIFE SCIENCES
- Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes
- (2019) Jan Benedikt Groener et al. PLoS One
- Decreased Blood Asprosin in Hyperglycemic Menopausal Women as a Result of Whole-Body Cryotherapy Regardless of Metabolic Syndrome
- (2019) Magdalena Wiecek et al. Journal of Clinical Medicine
- Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity
- (2019) Min Wang et al. ANNALS OF NUTRITION AND METABOLISM
- Sex differences in cardiometabolic disorders
- (2019) Eva Gerdts et al. NATURE MEDICINE
- Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus
- (2019) Xinyue Zhang et al. Journal of Diabetes Investigation
- The Asprosin-OLFR734 hormonal signaling axis modulates male fertility
- (2019) Fangchao Wei et al. Cell Discovery
- A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: Asprosin
- (2018) Ahmet Cagdas Acara et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion
- (2018) Yuren Wang et al. MEDIATORS OF INFLAMMATION
- Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome
- (2018) Murat Alan et al. GYNECOLOGICAL ENDOCRINOLOGY
- Serum asprosin levels and bariatric surgery outcomes in obese adults
- (2018) Chao-Yung Wang et al. INTERNATIONAL JOURNAL OF OBESITY
- GW29-e0080 The protective role of Asprosin against diabetes in cardiomyocytes
- (2018) Jian Feng et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Air Pollution and Cardiovascular Disease
- (2018) Sanjay Rajagopalan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases
- (2018) Xing Li et al. MEDIATORS OF INFLAMMATION
- Gender-related issues in the pharmacology of new anti-obesity drugs
- (2018) Mauro Cataldi et al. Obesity Reviews
- Acute Anaerobic Exercise Affects the Secretion of Asprosin, Irisin, and Other Cytokines – A Comparison Between Sexes
- (2018) Magdalena Wiecek et al. Frontiers in Physiology
- New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis
- (2018) Ting Yuan et al. Redox Biology
- Asprosin is a centrally acting orexigenic hormone
- (2017) Clemens Duerrschmid et al. NATURE MEDICINE
- Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride
- (2017) Lei Zhang et al. CLINICA CHIMICA ACTA
- Asprosin, a Fasting-Induced Glucogenic Protein Hormone
- (2016) Chase Romere et al. CELL
- Cardiac sympathetic afferent reflex and its implications for sympathetic activation in chronic heart failure and hypertension
- (2015) W.-W. Chen et al. Acta Physiologica
- Mechanisms of anorexia–cachexia syndrome and rational for treatment with selective ghrelin receptor agonist
- (2015) Angela Esposito et al. CANCER TREATMENT REVIEWS
- The Phyre2 web portal for protein modeling, prediction and analysis
- (2015) Lawrence A Kelley et al. Nature Protocols
- Targeting protein tyrosine phosphatase σ after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias
- (2015) R. T. Gardner et al. Nature Communications
- C-terminal propeptide is required for fibrillin-1 secretion and blocks premature assembly through linkage to domains cbEGF41-43
- (2014) S. A. Jensen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blood Glucose Responses to Type, Intensity, Duration, and Timing of Exercise
- (2013) S. R. Colberg et al. DIABETES CARE
- The Evolution of Extracellular Fibrillins and Their Functional Domains
- (2012) Adam Piha-Gossack et al. PLoS One
- Agouti-related protein in patients with acute and weight-restored anorexia nervosa
- (2011) J. V. Merle et al. PSYCHOLOGICAL MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started